Similar biotherapeutic products: overview and reflections.

Biotherapeutic products (BPs) have revolutionized medicine, changing the way we treat several pathologies such as autoimmune diseases and cancer, among others. Herein, we present an overview of similar BPs (SBPs), also called biosimilars, including the manufacturing process and regulatory aspects in...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2012

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/24284

Acceso en línea:

https://doi.org/10.2217/imt.12.128
https://repository.urosario.edu.co/handle/10336/24284

Palabra clave:

Biosimilar agent
Animal
Autoimmune disease
Biological therapy
Biotechnology
Drug approval
Drug design
Human
Methodology
Molecularly targeted therapy
Neoplasm
Review
Animals
Autoimmune diseases
Biological therapy
Biosimilar pharmaceuticals
Biotechnology
Drug approval
Drug design
Humans
Molecular targeted therapy
Neoplasms

Rights

License

Abierto (Texto Completo)